The global renal disease therapeutics market size is predicted to grow at an impressive CAGR between 2022 to 2027. Renal diseases are a progressive loss of the proper functioning of the kidneys. Over a more extended period, the associated renal system fuels the market because of its high incidence rate worldwide.
The kidneys have many life-sustaining functions, such as cleansing the blood by filtering waste products and excess fluid, regulating blood pressure, and maintaining the balance of salt and minerals. When kidney failure occurs, they ultimately lose their vital function, which is fatal. Kidney damage/failure can be developed acutely (AKI) and over time (CKD). Three types of treatment are most prevalent to cure kidney failure: prescription medications, surgical intervention, dialysis (peritoneal dialysis, hemodialysis, and continuous renal replacement therapy), which are frequently used in combination to treat a single case of renal failure.
Some of the key drivers of the Renal Disease Therapeutics Market are increasing aging population, growing awareness of both acute and chronic kidney disease, an increasing number of individuals with insurance due to the Affordable Care Act, Increasing Diabetic Population, and rising demand for advanced diagnostics and therapeutics for the disease.
Disparities of Renal Transplant Therapy, expiring of patents of some of the branded drugs for the late-stage CKD, and changing reimbursement scenarios in some significant countries, Negative Societal Effects are the restraints that hinder the growth of the market.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2021 to 2027 |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2027 |
|
Segments Covered |
By Application Mode, Treatment and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Hoffmann-La Roche Inc., Shire Inc., Fresenius Medical Care, Baxter International and Davita Healthcare Partners |
This research report on the global renal disease therapeutics market has been segmented and sub-segmented based on application mode, treatment, and region.
Renal Disease Therapeutics Market - By Application Mode:
Renal Disease Therapeutics Market - By Treatment:
Renal Disease Therapeutics Market - By Region:
Geographically, the North American market is predicted to dominate the global renal disease therapeutics market during the forecast period. Europe comes next. However, the Asia-Pacific is projected to show the highest CAGR over the forecast period due to an increasing number of high blood pressure and diabetic patients and a growing demand for advanced diagnostics and therapeutics in the region.
KEY MARKET PLAYERS:
Companies leading the global renal disease therapeutics market profiled in the report are Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Hoffmann-La Roche Inc., Shire Inc., Fresenius Medical Care, Baxter International, and Davita Healthcare Partners.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Application
5.1.1 Introduction
5.1.2 Kidney Stone Disease
5.1.3 End-Stage Kidney Disease
5.1.4 Kidney Failure
5.1.5 Chronic Kidney Disease
5.1.6 Hypertension
5.1.7 Diabetes
5.1.8 Anaemia
5.1.4 Y-o-Y Growth Analysis, By Application
5.1.5 Market Attractiveness Analysis, By Application
5.1.6 Market Share Analysis, By Application
5.2 Treatment devices
5.2.1 Introduction
5.2.2 Dialysis Equipment
5.2.3 Renal Denervation devices
5.2.4 Wearable artificial kidney device
5.2.5 distal embolic protection devices
5.2.6 Y-o-Y Growth Analysis, By Treatment devices
5.2.7 Market Attractiveness Analysis, By Treatment devices
5.2.8 Market Share Analysis, By Treatment devices
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Application
6.1.3.3 By Treatment Devices
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Application
6.1.4.3 By Treatment devices
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Application
6.1.5.3 By Treatmentr Devices
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Amgen Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck & Co., Inc.
8.3 Bristol-Myers Squibb Company
8.4 Hoffmann-La Roche Inc
8.5 Shire Inc.
8.6 Fresenius Medical Care
8.7 Baxter International
8.8 Davita Healthcare Partners
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
